SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,378,664 | -53.6% | 614,642 | -28.5% | 0.00% | -100.0% |
| Q2 2023 | $5,121,124 | +60.4% | 859,249 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $3,191,828 | -56.7% | 976,094 | -47.6% | 0.00% | -50.0% |
| Q4 2022 | $7,364,767 | -13.0% | 1,864,498 | +32.2% | 0.00% | 0.0% |
| Q3 2022 | $8,466,000 | +54.7% | 1,410,868 | +65.8% | 0.00% | +100.0% |
| Q2 2022 | $5,472,000 | +11.3% | 851,027 | +43.0% | 0.00% | 0.0% |
| Q1 2022 | $4,917,000 | -18.5% | 595,289 | +52.8% | 0.00% | 0.0% |
| Q4 2021 | $6,030,000 | -2.0% | 389,493 | +42.5% | 0.00% | 0.0% |
| Q3 2021 | $6,155,000 | -14.9% | 273,325 | -25.7% | 0.00% | -50.0% |
| Q2 2021 | $7,235,000 | +37.9% | 367,988 | +134.7% | 0.00% | +100.0% |
| Q1 2021 | $5,248,000 | – | 156,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |